Personalized medicine is a rapidly evolving health-care industry, in which an individual’s genetic profile is used to customize health management. Explosive advances in next-generation sequencing (NGS) and computational analyses have enabled the evaluation for prevention and early detection of cancers. With years of research and development experience in the field of NGS, Creative Biolabs has established an advanced SuPrecision™ platform to offer an accurate and high-throughput sequencing service to support cancer diagnosis and precision medicine.